Nitric oxide donors in sepsis: A systematic review of clinical and in vivo preclinical data

Shock

Volumn 30, Issue 6, 2008, Pages 653-659

  Lamontagne, Francois ^a   Meade, Maureen ^b   Ondiveeran, Hari Kumar ^a   Lesur, Olivier ^c   Robichaud, Alison E ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Departments of Medicine   (United States)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Animal research; Human; Nitric oxide; Septic shock

Indexed keywords

DIETHYLENETRIAMINE; FLURBIPROFEN; GLYCERYL TRINITRATE; LINSIDOMINE; LIPOPOLYSACCHARIDE; MOLSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PARACETAMOL; S NITROSOGLUTATHIONE;

ARTICLE; BLOOD PRESSURE; CLINICAL STUDY; DISEASE MODEL; DRUG MECHANISM; EXPERIMENTAL ANIMAL; HUMAN; IN VIVO STUDY; MORTALITY; NONHUMAN; ORGAN PERFUSION; OUTCOME ASSESSMENT; PULMONARY HYPERTENSION; SEPSIS; SYSTEMATIC REVIEW; TISSUE PERFUSION; TREATMENT OUTCOME;

ANIMALS; BLOOD PRESSURE; HUMANS; MICROCIRCULATION; NITRIC OXIDE DONORS; SEPSIS; TREATMENT OUTCOME;

EID: 58149229193     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181777eef     Document Type: Article

References (47)

1. Angus DC. Linde-Zwirble WT, Lidicker J. Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence. outcome. and associated costs of care. Crit Care Med 29:1303-1310. 2001.
2. Singh S. Evans TW: Organ dysfunction during sepsis. Intensive Care Med 32:349-360, 2006.
3. Ochoa JB. Udekwu AO, Billiar TR. Curran RD, Cerra FB, Simmons RL. Peitzman AB: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214:621-626. 1991.
4. Petros A. Bennett D. Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557-1558. 1991.
5. Bateman RM. Sharpe MD. Ellis CG: Bench-to-bedside review: microvascular dysfunction in sepsis-hemodynamics. oxygen transport. and nitric oxide. Crit Care 7:359-373. 2003.
6. Avontuur JA. Tutein Nolthenius RP, van Bodegom JW. Bruining HA: Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Cril Care Med 26:660-667, 1998.
7. Grover R. Zaccardelli D. Colice G. Guntupalli K. Watson D. Vincent JL: An open-label dose escalation study of the nitric oxide synthase inhibitor. NiGimethyl-L-arginine hydrochloride (546C88). in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med 27: 913-922. 1999.
8. Lopez A. Lorente JA. Steingrub J. Bakker J. McLuckie A. Willatts S. Brockway M. Anzueto A. Holzapfel L. Breen D. et al.: Multiple-center. randomized, placebo-controlled. double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21-30. 2004.
9. Gundersen Y. Corso CO. Leiderer R. Dorger M. Lilleaasen P. Aasen AO. Messmer K: The nitric oxide donor sodium nitroprusside protects against hepatic microcirculatory dysfunction in early endotoxaemia. Intensive Care Med 24:1257-1263. 1998.
10. Spronk PE. Ince C. Gardien MJ. Mathura KR. Oudemans-van Straaten HM. Zandstra DF: Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360:1395-1396. 2002.
11. Fox-Robichaud A. Payne D. Hasan SU. Ostrovsky L. Fairhead T. Reinhardt P. Kubes P: Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 101:2497-2505. 1998.
12. Fox-Robichaud A. Payne D. Kubes P: Inhaled NO reaches distal vasculatures to inhibit endothelium- but not leukocyte-dependent cell adhesion. Cell Mol Physiol 277:L1224-L1231. 1999.
13. Kubes P. Payne D. Grisham MB. Jourd-Heuil D. Fox-Robichaud A: Inhaled NO impacts vascular but not extravascular compartments in postischemic peripheral organs. Cire Physiol 277:H676-H682. 1999.
14. Piper RD. Cook DJ. Bone RC. Sibbald WJ: Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med 24:2059-2070, 1996.
15. Goto M. Zeller WP, Lichtenberg RC. Hurley RM: Diltiazem treatmenl of endotoxic shock in suckling rats. J Lab Clin Med 120:465-470. 1992.
16. Zingarelli B, Halushka PV. Caputi AP. Cook JA: Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock 3:102-108. 1995.
17. Kumins NH, Hunt J, Gamelli RL. Filkins JP: Molsidomine increases endotoxic survival and decreases cytokine production. Shock 7:200-205. 1997.
18. Cochran JB. Genovese F. Ogura S. Teti G. Cook JA: Effect of nitric oxide donors and nitric oxide synthase inhibitors in neonatal rat endotoxic shock. Biochem Pharmacol 58:687-691, 1999.
19. Brown KM. Brems JJ. Moazzam FN, Hartman GG. Gamelli RL, Ding JW: The nitric oxide donor molsidomine improves survival and reduces hepatocyte apoptosis in cholestasis and endotoxemia.. J Am Coll Surg 197:261 269. 2003.
20. Foulke GE. Fisher CJ Jr. Demling RH: Effect of nitroprusside on pulmonary hypertension and lung fluid balance after E. cali endotoxin. Crit Care Med 10:427-431. 1982.
21. Rudinsky BF. Komar KJ. Strates E. Meadow WL: Neither nitroglycerin nor nitroprusside selectively reduces sepsis-induced pulmonary hypertension in piglets. Crit Care Med 15:1127-1130. 1987.
22. Allen SJ. Drake RE, Katz J. Gabel JC. Laine GA: Lowered pulmonary arterial pressure prevents edema after endotoxin in sheep. J Appl Physiol 63: 1008-1011. 1987.
23. Wright P, Ishihara Y, Bernard GR: Effects of nitroprusside on lung mechanics and hemodynamics after endotoxemia in awake sheep. J Appl Physiol 64: 2026-2032, 1988.
24. Rudinsky B, Meadow W: Hemodynamic effects of combining epinephrine with nitroglycerin or nitroprusside during group B streptococcal sepsis in piglets. Am J Perinatol 9:435-440, 1992.
25. Koizumi T, Kubo K, Hirai K, Shinozaki S, Kobayashi T, Sekiguchi M, Sakai A: Effects of continuous infusion of nitroglycerin on pulmonary hemodynamics, lung lymph balance, and prostanoid products in the response to endotoxin in awake sheep. Lung 171:19-30, 1993.
26. Pastor CM, Payen DM: Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 2:196-202, 1994.
27. Pastor CM, Losser MR, Payen D: Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology 22:1547-1553, 1995.
28. Zhang H, Rogiers P, Friedman G, Preiser JC, Spapen H, Buurman WA, Vincent JL: Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endotoxic shock. Arch Surg 131:767-774, 1996.
29. Zhang H, Rogiers P, Smail N, Cabral A, Preiser JC, Peny MO, Vincent JL: Effects of nitric oxide on blood flow distribution and O2 extraction capabilities during endotoxic shock. J Appl Physiol 83:1164-1173, 1997.
30. Picunio S, Simioni M, Doni MG: Platelet activation and modulation of the induction of nitric oxide synthase in the conscious rat. Life Sci 65:1463-1475, 1999.
31. Lefilliatre P, Sogni P, Bertrand V, Del Soldato P, Pateron D, Moreau R, Lebrec D: Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: beneficial effects of a non-steroidal anti-inflammatory drug coupled with a nitric oxide donor. J Gastroenterol Hepatol 16:70-78, 2001.
32. Cerwinka WH, Cooper D, Krieglstein CF, Feelisch M, Granger DN: Nitric oxide modulates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Circ Physiol 282:H1111-H1117, 2002.
33. Kozlov AV, Albrecht M, Donnelly EM, Jafarmadar M, Szelenyi Z, Nohl H, Redl H, Bahrami S: Release and hemodynamic influence of nitroglycerinederived nitric oxide in endotoxemic rats. Vascul Pharmacol 43:411-414, 2005.
34. Marshall M, Keeble J, Moore PK: Effect of a nitric oxide releasing derivative of paracetamol in a rat model of endotoxaemia. Br J Pharmacol 149:516-522, 2006.
35. Liu DD, Hsu YH, Chen HI: Endotoxin-induced acute lung injury is enhanced in rats with spontaneous hypertension. Clin Exp Pharmacol Physiol 34:61-69, 2007.
36. Siegemund M, Van Bommel J, Sinaasappel M, Schwarte LA, Studer W, Girard T, Vollebregt K, Ince C: The NO donor SIN-1 improves intestinal-arterial P(CO(2)) gap in experimental endotoxemia: an animal study. Acta Anaesthesiol Scand 51:693-700, 2007.
37. Boughton-Smith NK, Hutcheson IR, Deakin AM, Whittle BJ, Moncada S: Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 191:485-488, 1990.
38. Cuzzolin L, Adami A, Crivellente F, Benoni G: Role of endogenous and exogenous nitric oxide on intestinal mucosa and microflora in the rat. Inflammation 21:443-450, 1997.
39. San T, Oktar BK, Salik E, Ercan F, Alican I: The effect of alpha-melanocyte stimulating hormone on endotoxin-induced intestinal injury. Peptides 22:2077-2082, 2001.
40. Walther A, Barth C, Gebhard MM, Martin E: Role of nitric oxide in leukocyteindependent endothelial damage during experimental endotoxemia. Shock 20:286-291, 2003.
41. Cerra FB, Hassett J, Siegel JH: Vasodilator therapy in clinical sepsis with low output syndrome. J Surg Res 25:180-183, 1978.
42. Dal Secco D, Moreira AP, Freitas A, Silva JS, Rossi MA, Ferreira SH, Cunha FQ: Nitric oxide inhibits neutrophil migration by a mechanism dependent on ICAM-1: role of soluble guanylate cyclase. Nitric Oxide 15:77-86, 2006.
43. Korbut R, Gryglewski RJ: The effect of prostacyclin and nitric oxide on deformability of red blood cells in septic shock in rats. J Physiol Pharmacol 47:591-599, 1996.
44. Gourine AV: Pharmacological evidence that nitric oxide can act as an endogenous antipyretic factor in endotoxin-induced fever in rabbits? Gen Pharmacol 26:835-841, 1995.
45. Gagalo IT, Hac EE, Korolkiewicz KZ, Matuszek MT, Szreder Z: Do sodium nitroprusside and L-NAME affect pyrogen fever in rabbits? Acta Physiol Hung 84:289-290, 1996.
46. Anuar F, Whiteman M, Siau JL, Kwong SE, Bhatia M, Moore PK: Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat. Br J Pharmacol 147:966-974, 2006.
47. Vincent JL, Zhang H, Szabo C, Preiser JC: Effects of nitric oxide in septic shock. Am J Resp Crit Care Med 161:1781-1785, 2000.